1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PROKIDNEY CORP - ORDINARY SHARES - CLASS A
ProKidney Corp - Ordinary Shares - Class A
XNAS: PROK
Download real time
1.660.09(5.73%)
52.30% Fall from 52W High
1.1M
XNAS Volume

XNAS 08 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

ProKidney Corp Ordinary quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for ProKidney Corp Ordinary share price target, revenues, EPS, net income and more

ProKidney Corp Ordinary quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • NEGATIVE

    Quarterly Revenue ProKidney Corp Ordinary Jun-2026 Quarterly Revenue is $0 Million which is growth of -32.1% YoY.

  • NEGATIVE

    Quarterly Net Profit ProKidney Corp Ordinary Jun-2026 Quarterly Net Profit is $-28 Million which is growth of -71.7% YoY.

ProKidney Corp - Ordinary Shares - Class A, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
0.20.20.20.20.20.20.1
Cost Of Rev.
-------------
Gross Profit
-------------
⌄
48.545.245.638.839.941.651.74943.140.124.246.639.8
Operating Profit
-48.4-44.9-45.4-38.5-39.7-41.4-51.6-49-43.1-40.1-24.2-46.6-39.8
⌄
1.92.32.93.33.644.85.64.54.85.35.56
Profit Before Tax
-46.4-42.6-42.4-35.3-36.1-37.4-46.8-43.4-38.5-35.2-18.9-41.1-33.9
Tax
-1.60.60.90.61.7-2.3-0.10.12.80.91
⌄
-28.4-20-19.2-16.5-16.6-16.7-21.3-17.9-12.5-9.5-5.7-11-9.1
Diluted NI Avail to Com Stockholders Ann.
-28.4-20-19.2-16.5-16.6-16.7-21.3-17.9-12.5-9.5-5.7-11-9.1
Basic EPS
-0.2-0.1-0.1-0.1-0.1-0.1-0.2-0.1-0.2-0.2-0.1-0.2-0.1
Diluted EPS After ExtraOrdinary
-0.2-0.1-0.1-0.1-0.1-0.1-0.2-0.1-0.2-0.2-0.1-0.2-0.1
Number Of Shares End
186.6141.9141135130.7129128.2126.275.96162.261.664.6
Net Income Continuing Discontinued Operations
-28.4-20-19.2-16.5-16.6-16.7-21.3-17.9-12.5-9.5-5.7-11-9.1
Normalized Income
-28.4-20-19.2-16.5-16.6-16.7-21.3-17.9-12.5-9.5-5.7-11-9.1
Interest Income
1.92.32.93.33.644.85.64.54.85.35.56
Interest
0
Net Interest Income
1.92.32.93.33.644.85.64.54.85.35.56
EBIT
-46.4-42.6-42.4-35.3-36.1-37.4-46.8-43.4-38.5-35.2-18.9-41.1-33.9
EBITDA
-44.8-41-40.6-33.6-34.7-35.8-45.2-41.9-37.3-34.1-17.8-40.1-33
Reconciled Cost Of Rev.
-------------
Reconciled Depr.
1.71.71.81.71.51.61.61.51.31.11.210.9
Profit From Continuing Operations
-46.4-42.6-40.9-35.8-37-38-48.5-41.1-38.5-35.3-21.7-42-34.8
Normalized EBITDA
-44.8-41-40.6-33.6-34.7-35.8-45.2-41.9-37.3-34.1-17.8-40.1-33
*All financials are in USD Million and price data in USD
Add metric to table
Search...

ProKidney Corp Ordinary competitor comparison and performance snapshot within industry

ProKidney Corp Ordinary annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue ProKidney Corp Ordinary Dec-2025 Annual Revenue is $1 Million which is growth of 1075.0% YoY.

  • NEGATIVE

    Annual Net Profit ProKidney Corp Ordinary Dec-2025 Annual Net Profit is $-69 Million which is growth of -12.7% YoY.

ProKidney Corp - Ordinary Shares - Class A, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20
⌄
-
-
 0.90.1
Cost Of Rev. Ann.
-
-
 ------
Gross Profit Ann.
-
-
 ------
Operating Exp. Ann.
2.7%
43.8%
178165.9183.8151.515355.127
Operating Profit Ann.
-
-
-177.2-165-183.7-151.5-153-55.1-27
⌄
33.5%
-
10.413.819.722.15.80
Other Exp. Ann.
-
-
 ------
PBT Ann.
-
-
-166.8-151.2-163.9-129.5-147.2-55.1-27
Tax Ann.
-23.7%
-
-10.4-0.660.90-0.2
⌄
-
-
-84.2-69-61.2-35.5-108-55.2-26.8
Diluted NI Avail to Com Stockholders Ann.
-
-
-84.2-69-61.2-35.5-108-55.2-26.8
EPS Ann.
-
-
 -0.5-0.6-0.6-0.2-0.3-0.1
Diluted EPS Ann.
-
-
 -0.5-0.6-0.6-0.2-0.3-0.1
Number Of Shares End
31.9%
-
 141128.262.261.5186.5-
Total Exp. Ann.
2.7%
43.8%
 165.9183.8151.515355.127
Net Income Continuing Discontinued Operations Ann.
-
-
-84.2-69-61.2-35.5-108-55.2-26.8
Normalized Income Ann.
-
-
-84.2-69-61.2-35.5-108-55.2-26.8
Interest Income Ann.
32%
-
10.513.819.822.160
Interest Ann.
-
-
0000.2-
EBITDA Ann.
-
-
-159.9-144.6-158.5-125.6-144-53.1-26
Reconciled Cost Of Rev. Ann.
-
-
 ------
Reconciled Depr. Ann.
30.1%
45.9%
6.86.65.43.9321
Profit From Continuing Operations Ann.
-
-
-165.8-151.6-163.3-135.5-148.1-55.2-26.8
Normalized EBITDA Ann.
-
-
-159.9-144.6-158.5-125.6-144-53.1-26
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
800%
Operating Exp. Ann.
1Y CHG
-9.7%
2Y CAGR
4.6%
3Y CAGR
2.7%
5Y CAGR
43.8%
Operating Expenses Annual Cr is falling faster than historical averages.

ProKidney Corp Ordinary balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund ProKidney Corp Ordinary Dec-2025 Total Shareholders Fund is $-1,011 Million which is growth of -1.6% YoY.

  • NEGATIVE

    Total Assets ProKidney Corp Ordinary Dec-2025 Total Assets is $336 Million which is growth of -23.9% YoY.

ProKidney Corp - Ordinary Shares - Class A, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20
⌄
-13.5%
82.2%
335.6441.1420.651840.316.7
⌄
38.5%
38.6%
34.839.429.213.113.46.8
⌄
-
-
-1,011.2-995-1,103.4-1,096.626.99.9
Total Capitalization Ann.
-
-
-1,011.2-995-1,103.4-1,096.626.99.9
Tangible Assets Ann.
-
-
-1,011.2-995-1,103.4-1,096.826.59.2
Working Capital Ann.
-20.3%
378.1%
249.9359.7349.1493.9150.1
Invested Capital Ann.
-
-
-1,011.2-995-1,103.4-1,096.626.99.9
Tangible Book Value Ann.
-
-
-1,011.2-995-1,103.4-1,096.826.59.2
Borrowings Ann.
18.6%
20.1%
43.24.42.41.31.6
Net Debt Ann.
-
-
------
Share Issued Ann.
32.1%
18.2%
141.8128.159.961.561.561.5
Number Of Shares End
31.9%
-
141128.262.261.5186.5-
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-23.9%
2Y CAGR
-10.7%
3Y CAGR
-13.5%
5Y CAGR
82.2%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-15.2%
2Y CAGR
10.8%
3Y CAGR
41.2%
5Y CAGR
41%
Total Current Liabilities Annual Cr is falling faster than historical averages.

ProKidney Corp Ordinary ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share ProKidney Corp Ordinary Book Value Per Share is $-4 which is growth of 43.1% YoY.

  • NEUTRAL

    ROE ProKidney Corp Ordinary ROE is 0% which is growth of 0% YoY.

ProKidney Corp - Ordinary Shares - Class A, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20
RoA Ann. %
-
-
--14.20%-7.56%-38.70%-193.50%-160.17%
ROE Ann. %
-
-
-----299.86%-271.18%
ROIC %
-
-
-----48.4-
OPM Ann. %
-
-
-18,477.83%-241,678.95%----
Inventory Turnover Ratio Ann.
-
-
------
Asset Turnover Ann. %
-
-
-----
Working Capital Turnover Ann.
-
-
Quick Ratio Ann.
-
-
-1014.645.11.70.8
Current Ratio Ann.
-
-
-10.914.946.42.21
Interest Coverage Ratio Ann.
-
-
--18,213.8-10,786.6-683.8--
LT Debt To Equity Ann.
-
-
----00.1
*All financials are in USD Million and price data in USD
Add metric to table
Search...

ProKidney Corp Ordinary cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity ProKidney Corp Ordinary Dec-2025 Cash From Operating Activity is $-120 Million which is growth of 4.9% YoY.

  • NEGATIVE

    Net Cash Flow ProKidney Corp Ordinary Dec-2025 Net Cash Flow is $9 Million which is growth of -75.5% YoY.

ProKidney Corp - Ordinary Shares - Class A, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20
⌄
-
-
-120.1-126.4-90.1-77.1-50.3-25.2
⌄
-
-
10420.4-330-1.7-5.2-5.5
⌄
-64%
5.1%
25.6144.4-9.6548.571.520
Cash Plus Cash Eqv. End Of Year Ann.
-39.5%
88.2%
108.599.160.7490.320.64.6
Net Increase In Cash Plus Cash Eqv.s Ann.
-72.9%
-
9.438.5-429.6469.716-10.7
Cash Plus Cash Eqv. Begin Of Year Ann.
68.8%
45.5%
99.160.7490.320.64.615.2
Income Tax Paid Supplemental Data Ann.
-
-
-0.12.92-0.1
Interest Paid Supplemental Data Ann.
-
-
------
Capex Ann.
-
-
-15.2-29.5-34.2-1.9-5.2-5.5
Issuance Of Capital Stock Ann.
-
-
24.3144.3----
Issuance Of Debt Ann.
-
-
-35-
Repayment Of Debt Ann.
-
-
-0-0.1-0.1-35-0-0
Repurchase Of Capital Stock Ann.
-
-
-9.5---
Free Cash Flow Ann.
-
-
-135.3-155.9-124.3-78.9-55.5-30.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Investing Act. Ann.
1Y CHG
409.8%
Cash from Investing Activity Annual growth is stable compared to historical averages.
Cash from Financing Act. Ann.
1Y CHG
-82.3%
3Y CAGR
-64%
5Y CAGR
5.1%
Cash from Financing Annual Activity is falling faster than historical averages.
×